Clinical Report: National Outcomes of Hiatal Hernia Repair and Fundoplication
Overview
This study evaluates the short-term perioperative outcomes of patients undergoing magnetic sphincter augmentation (MSA) device removal with concurrent hiatal hernia repair (HHR) and fundoplication.
Background
Gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal disorder that often requires surgical intervention when medical management fails. Magnetic sphincter augmentation (MSA) has emerged as an alternative to traditional fundoplication, but device removal may necessitate additional surgical procedures such as HHR and fundoplication. Understanding the outcomes of these combined procedures is crucial for optimizing patient care.
Data Highlights
Outcome
MSA Device Explant with HHR and Fundoplication
Primary HHR and Fundoplication
Number of Patients
40
40
Mean Age
58.3 years
58.8 years
Mean BMI
29.1 kg/m²
28.9 kg/m²
Key Findings
No significant differences in demographics between the MSA explant group and the primary repair group.
Both cohorts had similar rates of 30-day complications.
Operative time and length of stay were comparable between the two groups.
Propensity score matching was utilized to minimize confounding factors.
The study included a large sample size from the ACS-NSQIP database, enhancing the reliability of the findings.
Clinical Implications
The findings suggest that concurrent MSA device removal with HHR and fundoplication does not increase the risk of short-term complications compared to primary procedures. This information may assist surgeons in decision-making for patients requiring device explantation.
Conclusion
The study provides evidence that the short-term outcomes of concurrent MSA device explant with HHR and fundoplication are comparable to those of primary HHR and fundoplication, supporting the safety of this surgical approach.
